Clinical Study to Evaluate the Safety and Efficacy of IM21 CAR-T Cells in the Treatment of Elderly Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT04537442 · UNKNOWN
Trial details
- NCT number
- NCT04537442
- Sponsor
- Beijing Immunochina Medical Science & Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-03
- Primary completion
- 2022-12-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.